Livingstone Health Holdings Limited (SGX:PRH)
Singapore · Delayed Price · Currency is SGD 0.0250
0.00 (0.00%)
At close: Aug 28, 2026
SGX:PRH Income Statement
Financials in millions SGD. Fiscal year is April - March.
Millions SGD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 29.29 | 27.65 | 25.37 | 32.92 | 34.14 |
Other Revenue | 0.03 | 0.01 | 0.04 | - | - |
Revenue | 29.32 | 27.66 | 25.41 | 32.92 | 34.14 |
Revenue Growth | 6.02% | 8.85% | -22.82% | -3.58% | 75.78% |
Cost of Revenue | 22.4 | 20.8 | 20.49 | 24.48 | 24.46 |
Gross Profit | 6.92 | 6.86 | 4.92 | 8.44 | 9.68 |
Selling, General & Admin | 2.74 | 2.39 | 1.98 | 2.78 | 2.38 |
Other Operating Expenses | 2.01 | 1.74 | 2.83 | 2.13 | 1.79 |
Operating Expenses | 7.19 | 6.67 | 7.07 | 6.84 | 5.71 |
Operating Income | -0.26 | 0.19 | -2.15 | 1.6 | 3.97 |
Interest Expense | -0.23 | -0.4 | -0.32 | -0.26 | -0.34 |
Interest & Investment Income | 0.01 | 0.04 | 0.01 | 0.01 | 0.01 |
Earnings From Equity Investments | -0.08 | -0.03 | -0.03 | - | -0.14 |
Other Non Operating Income (Expenses) | - | - | -0 | -0.05 | - |
EBT Excluding Unusual Items | -0.56 | -0.2 | -2.49 | 1.3 | 3.5 |
Impairment of Goodwill | - | - | -0.17 | - | - |
Gain (Loss) on Sale of Investments | - | 0.06 | - | - | - |
Gain (Loss) on Sale of Assets | -0.06 | 0.01 | -0.03 | 0 | 0.04 |
Asset Writedown | -0.09 | -0.05 | -0.18 | -0.05 | -0.04 |
Other Unusual Items | 0.22 | 0.26 | 0.16 | 0.55 | 0.75 |
Pretax Income | -0.49 | 0.07 | -2.71 | 1.8 | 4.25 |
Income Tax Expense | 0 | -0.1 | 0.19 | 0.51 | 0.7 |
Earnings From Continuing Operations | -0.5 | 0.17 | -2.9 | 1.29 | 3.54 |
Net Income to Company | -0.5 | 0.17 | -2.9 | 1.29 | 3.54 |
Minority Interest in Earnings | 0.72 | 0.39 | 0.03 | -0.56 | -0.52 |
Net Income | 0.22 | 0.56 | -2.87 | 0.72 | 3.02 |
Net Income to Common | 0.22 | 0.56 | -2.87 | 0.72 | 3.02 |
Net Income Growth | -59.93% | - | - | -76.11% | - |
Shares Outstanding (Basic) | 624 | 580 | 442 | 436 | 319 |
Shares Outstanding (Diluted) | 712 | 671 | 442 | 436 | 319 |
Shares Change | 6.15% | 51.65% | 1.32% | 36.85% | 0.93% |
EPS (Basic) | 0.00 | 0.00 | -0.01 | 0.00 | 0.01 |
EPS (Diluted) | 0.00 | 0.00 | -0.01 | 0.00 | 0.01 |
EPS Growth | -62.63% | - | - | -82.54% | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 2.83 | 4.02 | 0.44 | 2.11 | 3.67 |
Free Cash Flow Per Share | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 |
Dividend Per Share | - | - | - | - | 0.001 |
Dividend Growth | - | - | - | - | - |
Gross Margin | 23.61% | 24.80% | 19.36% | 25.63% | 28.37% |
Operating Margin | -0.89% | 0.67% | -8.47% | 4.86% | 11.63% |
Profit Margin | 0.76% | 2.01% | -11.30% | 2.20% | 8.86% |
Free Cash Flow Margin | 9.66% | 14.55% | 1.74% | 6.41% | 10.75% |
EBITDA | 2.15 | 2.71 | 0.1 | 3.52 | 5.52 |
EBITDA Margin | 7.35% | 9.80% | 0.38% | 10.70% | 16.15% |
D&A For EBITDA | 2.42 | 2.53 | 2.25 | 1.93 | 1.54 |
EBIT | -0.26 | 0.19 | -2.15 | 1.6 | 3.97 |
EBIT Margin | -0.89% | 0.67% | -8.47% | 4.86% | 11.63% |
Effective Tax Rate | - | - | - | 28.45% | 16.56% |